Future studies determining the E3 ligases that mediate LAG-3/MHC-II expression and function regulation can help elucidate the role of E3 ligases in tumor immune response and develop related targeted drugs to strengthen immune surveillance. This evidence concerns the gene LAG3 and neoplasm.